Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 4, Avril 2003
Page(s) 405 - 407
Section Le Magazine : Nouvelles
DOI https://doi.org/10.1051/medsci/2003194405
Publié en ligne 15 avril 2003
  1. Dalchau R, Kirkley J, Fabre JW. Monoclonal antibody to a human braingranulocyte- T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur J Immunol 1980; 10: 745–9.
  2. Naor D, Sionov RV, Ish- Shalom D. CD44: Structure, function and association with the malignant process. In: Vande Woude GF, Klein G, eds. Advances in cancer research. San-Diego: Academic Press, 1997 : 243–318.
  3. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44: a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10: 423–8.
  4. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 1994; 6: 726–33.
  5. Günthert U, Hofmann M, Rudy S, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65 : 13–24.
  6. Seiter S, Arch R, Reber S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443–55.
  7. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b. Nature 1993 : 361: 79–82.
  8. Bennett KL, Jackson DG, Simon JC, et al. CD44 isoforms containing exon v3 are responsible for the presentation of heparinbinding growth factor. J Cell Biol 1995; 128: 687–98
  9. Sherman L, Wainwright D, Ponta H, Herrlich P. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 1998; 12: 1058–71.
  10. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 2002; 16: 3074–86.
  11. Birchmeier C, Gherardi E Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404–10.
  12. Nestl A, Von Stein OD, Zatloukal K, et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 2001; 61: 1569–77.
  13. Legg JW, Isacke CM. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol 1998; 8: 705–8.
  14. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993; 363: 515–21.
  15. Morrison H, Sherman LS, Legg J, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001; 15: 968–80.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.